Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists present an overview of the current knowledge of colitis-associated cancer (CAC) in inflammatory bowel disease (IBD) patients, focusing on the role of inflammation in the pathogenesis of CAC and the potential for IBD drugs to interfere with the process of carcinogenesis by reducing the inflammatory process or by modulating pathways directly involved in carcinogenesis.
[Digestive and Liver Disease]
1254621 {1254621:WXST2YCD} apa 50 1 158802 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-ca21426ba9df1f0be5e4d3f7cf111abd%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22WXST2YCD%22%2C%22library%22%3A%7B%22id%22%3A1254621%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fantini%20and%20Guadagni%22%2C%22parsedDate%22%3A%222021-02-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFantini%2C%20M.%20C.%2C%20%26amp%3B%20Guadagni%2C%20I.%20%282021%29.%20From%20inflammation%20to%20colitis-associated%20colorectal%20cancer%20in%20inflammatory%20bowel%20disease%3A%20Pathogenesis%20and%20impact%20of%20current%20therapies.%20%3Ci%3EDigestive%20and%20Liver%20Disease%3C%5C%2Fi%3E%2C%20%3Ci%3E0%3C%5C%2Fi%3E%280%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.dld.2021.01.012%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.dld.2021.01.012%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1254621%26amp%3Bitem_key%3DWXST2YCD%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22From%20inflammation%20to%20colitis-associated%20colorectal%20cancer%20in%20inflammatory%20bowel%20disease%3A%20Pathogenesis%20and%20impact%20of%20current%20therapies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Massimo%20Claudio%22%2C%22lastName%22%3A%22Fantini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilaria%22%2C%22lastName%22%3A%22Guadagni%22%7D%5D%2C%22abstractNote%22%3A%22%3Ch2%3EAbstract%3C%5C%2Fh2%3E%3Cp%3EThe%20risk%20of%20colorectal%20cancer%20%28CRC%29%20is%20higher%20in%20patients%20with%20inflammatory%20bowel%20disease%20%28IBD%29.%20Population-based%20data%20from%20patients%20with%20ulcerative%20colitis%20%28UC%29%20estimate%20that%20the%20risk%20of%20CRC%20is%20approximately%202-%20to%203-fold%20that%20of%20the%20general%20population%3B%20patients%20with%20Crohn%27s%20disease%20appear%20to%20have%20a%20similar%20increased%20risk.%20However%2C%20the%20true%20extent%20of%20colitis-associated%20cancer%20%28CAC%29%20in%20undertreated%20IBD%20is%20unclear.%20Data%20suggest%20that%20the%20size%20%28i.e.%2C%20severity%20and%20extent%29%20and%20persistence%20of%20the%20inflammatory%20process%20is%20largely%20responsible%20for%20the%20development%20of%20CRC%20in%20IBD.%20As%20patients%20with%20IBD%20and%20CRC%20have%20a%20worse%20prognosis%20than%20those%20without%20a%20history%20of%20IBD%2C%20the%20impact%20of%20current%20therapies%20for%20IBD%20on%20CAC%20is%20of%20importance.%20Chronic%20inflammation%20of%20the%20gut%20has%20been%20shown%20to%20increase%20the%20risk%20of%20developing%20CAC%20in%20both%20UC%20and%20CD.%20Therefore%2C%20control%20of%20inflammation%20is%20pivotal%20to%20the%20prevention%20of%20CAC.%20This%20review%20presents%20an%20overview%20of%20the%20current%20knowledge%20of%20CAC%20in%20IBD%20patients%2C%20focusing%20on%20the%20role%20of%20inflammation%20in%20the%20pathogenesis%20of%20CAC%20and%20the%20potential%20for%20IBD%20drugs%20to%20interfere%20with%20the%20process%20of%20carcinogenesis%20by%20reducing%20the%20inflammatory%20process%20or%20by%20modulating%20pathways%20directly%20involved%20in%20carcinogenesis.%3C%5C%2Fp%3E%22%2C%22date%22%3A%222021%5C%2F02%5C%2F01%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.dld.2021.01.012%22%2C%22ISSN%22%3A%221590-8658%2C%201878-3562%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.dldjournalonline.com%5C%2Farticle%5C%2FS1590-8658%2821%2900018-9%5C%2Fabstract%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-02-05T19%3A13%3A10Z%22%7D%7D%5D%7D
Fantini, M. C., & Guadagni, I. (2021). From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies. Digestive and Liver Disease, 0(0). https://doi.org/10.1016/j.dld.2021.01.012 Cite
